# GHK-Cu: Copper-Tripeptide Research Digest — Collagen, Genes, Skin

> GHK-Cu stimulates fibroblast collagen synthesis at nanomolar concentrations and modulates about 31% of human genes toward repair programs. A sourced digest of the copper-tripeptide literature.

One signal, liberated from collagen, that tells fibroblasts to rebuild the matrix around them. This is the published record — what each model measured, and where the human data stops.

## What the GHK-Cu record establishes

GHK-Cu is the glycyl-L-histidyl-L-lysine copper(II) complex, a copper-binding tripeptide present in human plasma, saliva, and urine. In human fibroblast cultures it raises collagen synthesis dose-dependently, with the effect beginning between 10⁻¹² and 10⁻¹¹ M and peaking near 10⁻⁹ M, all without any change in cell number [1]. At the genome level, a Connectivity Map analysis reports that GHK alters expression of about 31.2% of human genes at a 50%-or-greater change threshold — 59% upregulated, 41% downregulated — with strong stimulation of the ubiquitin-proteasome system (41 genes up, 1 down) and of DNA-repair and antioxidant gene sets [2].

The sequence is not foreign to the body. GHK occurs within the alpha-2(I) chain of type I collagen and in SPARC/osteonectin, and is liberated during tissue injury. Plasma GHK falls from roughly 200 ng/mL (10⁻⁷ M) at age 20 to about 80 ng/mL by age 60 [3]. That decline, tracking the body's regenerative capacity, is the basis for treating GHK-Cu as a repair signal rather than a drug imposed from outside.

What the literature does NOT yet contain is large controlled human evidence. The strongest randomized signal is a 45-patient hair-loss trial of a 5-aminolevulinic-acid + GHK combination, not pure GHK-Cu [4]. Topical skin trials are small. No validated human pharmacokinetics exist for injectable or systemic use. This digest leads with the measured findings and marks the gaps as gaps.

## GHK copper peptide: what the research describes

[GHK-Cu mechanism of action](/research) rests on a dual identity. The GHK copper peptide is at once a copper chaperone and a signaling molecule. As a chaperone, it delivers copper(II) in a tightly bound 1:1 complex — stability constant log K around 16.4 — high enough to limit free-copper release while still enabling copper-dependent enzymes such as lysyl oxidase, which cross-links collagen and elastin, and superoxide dismutase, which clears free radicals [6].

As a signal, GHK-Cu instructs dermal fibroblasts to synthesize collagen, elastin, glycosaminoglycans, and the proteoglycan decorin, while rebalancing matrix metalloproteinases against their TIMP inhibitors so remodeling favors construction over breakdown [3][6]. A 2008 tissue-remodeling review catalogued the full profile: increased VEGF, FGF-2, NGF, and neurotrophins 3 and 4; suppression of TGF-beta-1, TNF-alpha, free radicals, and protein glycation; and chemoattraction of repair cells [6]. The breadth is the point — GHK copper peptide is studied as a coordinating signal, not a single-target agent.

## Copper peptides and the GHK-Cu complex

The copper peptide class is small, and GHK-Cu is its most-studied member. A copper peptide is a short peptide chelated to a copper ion, where the copper is not a contaminant but a functional part of the molecule. In GHK-Cu, copper coordinates through the histidine imidazole nitrogen, the glycine alpha-amino nitrogen, and a deprotonated amide nitrogen, leaving the lysine side chain free [3].

That coordination matters: the free GHK peptide does not reproduce the copper complex's MMP-2 stimulation in fibroblast cultures, and copper binding is required for most documented tissue-repair activities [3]. The complex is also more stable than the free peptide, which plasma peptidases clear rapidly to the dipeptide histidyl-lysine after intravenous dosing in rats [10]. Within the copper-peptide family, GHK-Cu is the form with the deepest mechanistic and clinical record — explored further in [copper peptide benefits](/copper-peptide-benefits) and [copper peptide skin research](/copper-peptide-skin).

## Anchored questions

### What is copper peptide chemistry, in one definition?

A copper peptide is a short amino-acid chain bound to a copper(II) ion, where the copper is integral to the molecule's activity. GHK-Cu — glycyl-histidyl-lysine chelated 1:1 to copper — is the archetype. The copper enables cross-linking and antioxidant enzymes, and copper coordination is required for most of GHK-Cu's documented matrix-remodeling effects in fibroblast studies [3].

### Copper Tripeptide-1: the cosmetic-ingredient name for GHK-Cu

Copper Tripeptide-1 is the INCI (cosmetic-ingredient) name for GHK-Cu. The two terms denote the same molecule — glycyl-L-histidyl-L-lysine copper(II), CAS 89030-95-5, molecular weight 402.92 Da. Skincare labels use "Copper Tripeptide-1" to declare copper-peptide content; the research literature uses "GHK-Cu." Topical Copper Tripeptide-1 carries a long cosmetic safety record, whereas injectable or systemic GHK-Cu is unapproved and research-only.

### Is GHK-Cu peptide really anti-aging?

Research frames GHK-Cu as a gene-modulation and matrix-synthesis agent rather than a cosmetic claim. A 2015 review reports topical GHK-Cu increased procollagen production in 70% of treated subjects, versus 50% for vitamin C and 40% for retinoic acid [3], and aged-fibroblast work shows reversal of senescence markers p21 and p53 [15]. The evidence is mostly in vitro, rodent, and small topical-trial scale — strong on mechanism, thin on large controlled human outcomes.

### Why does GHK decline with age?

Plasma GHK falls from approximately 200 ng/mL (10⁻⁷ M) at age 20 to about 80 ng/mL by age 60 [3][7]. The decline parallels the body's reduced regenerative capacity, which is the basis for the age-related-decline hypothesis: as the endogenous repair signal drops, so does the matrix-renewal program it drives. The causal direction is not fully resolved in the literature.

### What is the GHK-Cu mechanism of action?

GHK-Cu acts as both a copper chaperone and a signaling molecule. At picomolar-to-nanomolar levels it stimulates fibroblast collagen, elastin, and glycosaminoglycan synthesis, rebalances MMPs against TIMPs, and the copper ion supports lysyl-oxidase cross-linking and SOD-like antioxidant activity, while broadly modulating gene expression [2][6]. The [GHK-Cu mechanism of action](/research) is detailed on the research page.

### What does a GHK-Cu peptide do?

In research models GHK-Cu stimulates synthesis of collagen, elastin, glycosaminoglycans, and decorin; modulates matrix-remodeling enzymes; supports angiogenesis via VEGF and FGF-2; and acts as an antioxidant copper carrier across wound, skin, and tissue-repair studies [3][6]. Its documented activity is coordinated tissue repair, observed mostly in vitro and in rodents.

### What is GHK-Cu and how does it work?

GHK-Cu is the glycyl-L-histidyl-L-lysine copper(II) complex, an endogenous copper-binding tripeptide. It works by chaperoning copper and signaling fibroblasts and other cells to remodel the extracellular matrix, while shifting broad gene-expression programs toward repair, DNA fidelity, and antioxidant defense [2][6]. Copper coordination is required for most of these effects.

### What is the difference between GHK and GHK-Cu?

GHK is the free tripeptide (MW 340.38, CAS 49557-75-7); GHK-Cu is the copper(II) chelate (MW 402.92, CAS 89030-95-5). Copper coordination is required for most documented tissue-repair activities — the free peptide does not reproduce MMP-2 stimulation in fibroblast cultures [3]. The literature frequently conflates the two forms, so the form a given study used always matters.

---

A living digest grown from one endogenous copper signal — every collagen figure, gene-modulation map, and hair-count trial traced back to its source, with no clinic behind the membrane and nothing here dispensed.